TAR-200 plus cetrelimab effective in reducing tumor size in those with muscle-invasive disease, potentially improving surgical outcomes and lowering risk of recurrence "These findings from the SunRISe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback